# The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

> **NCT03857477** · — · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 4700 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **GENETIC:** Genetic SNP profiling
- **OTHER:** Prostate cancer screening
- **PROCEDURE:** MRI Scan
- **PROCEDURE:** Prostate biopsy

## Key facts

- **NCT ID:** NCT03857477
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-14
- **Primary completion:** 2024-04-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 4700 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857477, "The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03857477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*